Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Devine

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Clinical Pharmacology and Therapeutics|February 5, 2017
Associations of High-Dose Melphalan Pharmacokinetics and Outcomes in the Setting of a Randomized Cryotherapy TrialY K Cho, D W Sborov, M Lamprecht, et al.
Bone Marrow Transplantation|August 1, 1997
Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiationR B Geller, S M Devine, K O'Toole, et al.
Bone Marrow Transplantation|February 1, 1996
Association of busulfan area under the curve with veno-occlusive disease following BMTS P Dix, J R Wingard, R E Mullins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 1997
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxisS M Devine, R B Geller, L B Lin, et al.
Blood|September 25, 1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantationV Ratanatharathorn, R A Nash, D Przepiorka, et al.
Bone Marrow Transplantation|April 28, 2015
Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcomeS D Goyal, M-J Zhang, H-L Wang, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Clinical Pharmacology and Therapeutics|February 5, 2017
Associations of High-Dose Melphalan Pharmacokinetics and Outcomes in the Setting of a Randomized Cryotherapy TrialY K Cho, D W Sborov, M Lamprecht, et al.
Bone Marrow Transplantation|August 1, 1997
Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiationR B Geller, S M Devine, K O'Toole, et al.
Bone Marrow Transplantation|February 1, 1996
Association of busulfan area under the curve with veno-occlusive disease following BMTS P Dix, J R Wingard, R E Mullins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 1997
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxisS M Devine, R B Geller, L B Lin, et al.
Blood|September 25, 1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantationV Ratanatharathorn, R A Nash, D Przepiorka, et al.
Bone Marrow Transplantation|April 28, 2015
Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcomeS D Goyal, M-J Zhang, H-L Wang, et al.
Pageof 5